Nova Pharmaceutical Corp said theU.S. Patent Office has allowed its patent for bradykininantagonist drugs. Nova said patents have also been filed inother countries worldwide.    It said it has the exclusive worldwide rights to thesepatents for the first bradykinin blocking drugs being developedas topical pain relievers and in nasal spry form for treatingcommon cold symptoms.    Nova said Bradykinin is the most powerful paing-producingsubstance in the body and is considered, based on scientificevidence, to be the initial stimulus of pain. Reuter&#3;